Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1963 May 1;117(5):705–716. doi: 10.1084/jem.117.5.705

IN VITRO STUDIES OF ULCERATIVE COLITIS

I. REACTIONS OF PATIENTS' SERUM WITH HUMAN FETAL COLON CELLS IN TISSUE CULTURES

Ove Broberger 1, Peter Perlmann 1
PMCID: PMC2137646  PMID: 14015587

Abstract

By means of immunofluorescent methods it has been shown that sera from children with ulcerative colitis contain antibodies which react with fetal colon cells in tissue culture. 5 out of 13 sera from patients reacted positively when tested for staining antibodies while 12 sera from healthy individuals yielded negative results. The specificity of the staining reactions was confirmed by inhibition experiments. The staining capacity of various sera was correlated to their hemagglutinating titer when tested against phenol-water extracts of human colon. The presence of blood group substances of the ABO system on fetal colon cells in tissue culture could be demonstrated by application of fluorescent H agglutinins from eel. Cross-inhibition experiments indicated that the H agglutinins stained colon antigens which were different from those reacting with the antibodies of ulcerative colitis sera. The reactivity of cultured fetal colon cells with the antibodies in ulcerative colitis sera was retained for up to 12 days, with optimal staining at 4 to 5 days. Reactivity with H agglutinins was present for a longer period, sometimes more than 20 days. Although antigen could be shown to be present on fetal colon cells in tissue culture, exposure of the culture, in the presence of fresh guinea pig serum, to sera from patients with ulcerative colitis did not lead to any visible cytotoxic damage. In order to investigate the possible cytotoxic effect of the sera with a more sensitive technique, freshly explanted fetal colon was dispersed by trypsinization and the cells labeled with 32P-orthophosphate. Subsequently, these cells were exposed to sera, in a final concentration of 30 per cent, from patients or healthy controls in the presence of fresh guinea pig serum (final concentration 15 per cent). Approximately 20 per cent of the cellular isotope was released into the medium within 150 minutes of incubation, but the release was the same in the samples treated either with patients' sera or normal control sera. Thus, under the present conditions, the patients' sera did not exert any specific cytotoxic action on colon cells.

Full Text

The Full Text of this article is available as a PDF (697.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHERSON G. L., BROBERGER O. Incidence of haemagglutinating and complement-fixing antibodies. Br Med J. 1961 May 20;1(5237):1429–1433. doi: 10.1136/bmj.1.5237.1429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BICKIS I. J., QUASTEL J. H., VAS S. I. Effects of Ehrlich ascites antisera on the biochemical activities of Ehrlich ascites carcinoma cells in vitro. Cancer Res. 1959 Jul;19(6 Pt 1):602–607. [PubMed] [Google Scholar]
  3. BRAND K. G., SYVERTON J. T. Results of species-specific hemagglutination tests on "transformed," nontransformed, and primary cell cultures. J Natl Cancer Inst. 1962 Jan;28:147–157. [PubMed] [Google Scholar]
  4. BROBERGER O., PERLMANN P. Autoantibodies in human ulcerative colitis. J Exp Med. 1959 Nov 1;110:657–674. doi: 10.1084/jem.110.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BROBERGER O., PERLMANN P. Demonstration of an epithelial antigen in colon by means of fluorescent antibodies from children with ulcerative colitis. J Exp Med. 1962 Jan 1;115:13–26. doi: 10.1084/jem.115.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. COLTER J. S., KRITCHEVSKY D., BIRD H. H., MCCANDLESS R. F. In vitro studies with antisera against tumor cell protein fractions. Cancer Res. 1957 May;17(4):272–276. [PubMed] [Google Scholar]
  7. DONIACH D., ROITT I. M. Auto-antibodies in disease. Annu Rev Med. 1962;13:213–240. doi: 10.1146/annurev.me.13.020162.001241. [DOI] [PubMed] [Google Scholar]
  8. EAGLE H. Amino acid metabolism in mammalian cell cultures. Science. 1959 Aug 21;130(3373):432–437. doi: 10.1126/science.130.3373.432. [DOI] [PubMed] [Google Scholar]
  9. FORBES I. J., ROITT I. M., DONIACH D., SOLOMON I. L. The thyroid cytotoxic autoantibody. J Clin Invest. 1962 May;41:996–1006. doi: 10.1172/JCI104579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GREEN H., BARROW P., GOLDBERG B. Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes. J Exp Med. 1959 Nov 1;110:699–713. doi: 10.1084/jem.110.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GREEN H., GOLDBERG B. The action of antibody and complement on mammalian cells. Ann N Y Acad Sci. 1960 May 31;87:352–362. doi: 10.1111/j.1749-6632.1960.tb23205.x. [DOI] [PubMed] [Google Scholar]
  12. HOLMBERG B. On the permeability to lissamine green and other dyes in the course of cell injury and cell death. Exp Cell Res. 1961 Jan;22:406–414. doi: 10.1016/0014-4827(61)90118-5. [DOI] [PubMed] [Google Scholar]
  13. HOLTZER H., HOLTZER S. The in vitro uptake of fluorescein labelled plasma proteins. I. Mature cells. C R Trav Lab Carlsberg. 1960;31:373–408. [PubMed] [Google Scholar]
  14. IRVINE W. J. The cytotoxic factor in thyroid disease. Scott Med J. 1960 Dec;5:511–522. doi: 10.1177/003693306000501202. [DOI] [PubMed] [Google Scholar]
  15. Irvine W. J. Studies on the Cytotoxic Factor in Thyroid Disease. Br Med J. 1962 May 26;1(5290):1444–1442.4. doi: 10.1136/bmj.1.5290.1444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. KOFFLER D., GARLOCK J., ROTHMAN W. Immunocytochemical reactions of serum from ulcerative colitis patients. Proc Soc Exp Biol Med. 1962 Feb;109:358–360. doi: 10.3181/00379727-109-27202. [DOI] [PubMed] [Google Scholar]
  17. LAGERCRANTZ R., WINBERG J., ZETTERSTROM R. Extra-colonic manifestations in chronic ulcerative colitis. Acta Paediatr. 1958 Nov;47(6):675–687. doi: 10.1111/j.1651-2227.1958.tb07683.x. [DOI] [PubMed] [Google Scholar]
  18. LEVINE S. Effect of manipulation on 32P loss from tissue culture cells. Exp Cell Res. 1960 Mar;19:220–227. doi: 10.1016/0014-4827(60)90003-3. [DOI] [PubMed] [Google Scholar]
  19. PULVERTAFT R. J., DONIACH D., ROITT I. M., HUDSON R. V. Cytotoxic effects of Hashimoto serum on human thyroid cells in tissue culture. Lancet. 1959 Aug 29;2(7096):214–216. doi: 10.1016/s0140-6736(59)90161-8. [DOI] [PubMed] [Google Scholar]
  20. PULVERTAFT R. J., DONIACH D., ROITT I. M. The cytotoxic factor in Hashimoto's disease and its incidence in other thyroid diseases. Br J Exp Pathol. 1961 Oct;42:496–503. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES